966
Views
6
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

A comparison of the inhibitory effect of nano-encapsulated helenalin and free helenalin on telomerase gene expression in the breast cancer cell line, by real-time PCR

, , , , , & show all
Pages 695-703 | Received 08 Oct 2014, Accepted 21 Oct 2014, Published online: 01 Dec 2014

References

  • Abbasi E, Akbarzadeh A, Kouhi M, Milani M. 2014a. Graphene: synthesis, bio-applications, and properties. Artif Cells Nanomed Biotechnol. 30:1–7.
  • Abbasi E, Aval SF, Akbarzadeh A, Milani M, Nasrabadi HT, Hanifepour Y, et al. 2014b. Dendrimers: synthesis, applications, and properties. Nanoscale Res Lett. 9:247.
  • Abbasi E, Milani M, Fekri Aval S, Kouhi M, Akbarzadeh A, Nasrabadi HT, et al. 2014c. Silver nanoparticles: Synthesis, properties, bio-applications and limitations. Crit Rev Microbiol. (Epub ahead of print).
  • Abbasi E, Milani M, Fekri Aval S, Kouhi M, Akbarzadeh A, Tayefi Nasrabadi H. 2014d. Silver nanoparticles: synthesis, properties, bio-applications and limitations. Crit Rev Microbiol(Epub ahead of print).
  • Ahmadi A, Shirazi H, Pourbagher N, Akbarzadeh A, Omidfar K 2014. An electrochemical immunosensor for digoxin using core-shell gold coated magnetic nanoparticles as labels. Mol Biol Rep. 41:1659–1668.
  • Akbarzadeh A, Mikaeili H, Asgari D, Zarghami N, Mohammad R, Davaran S. 2012b. Preparation and in-vitro evaluation of doxorubicin-loaded Fe3O4 magnetic nanoparticles modified with biocompatible copolymers Int J Nanomedicine 7:511–526.
  • Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y, et al. 2013. Liposome: classification, preparation, and applications. Nanoscale Res Lett 8:102.
  • Akbarzadeh A, Samiei M, Davaran S. 2012a. Magnetic nanoparticles: preparation, physical properties and applications in biomedicine Nanoscale Res Lett 7:144–157.
  • Akbarzadeh A, Samiei M, Joo SW, Anzaby M, Hanifehpour Y, Nasrabadi HT, Davaran S 2012d. Synthesis, characterization and in vitro studies of doxorubicin-loaded magnetic nanoparticles grafted to smart copolymers on A549 lung cancer cell line J Nanobiotechnol 10:46–58.
  • Akbarzadeh A, Zarghami N, Mikaeili H, Asgari D, Goganian AM, Khiabani HK, Davaran S. 2012c. Synthesis, characterization and in vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled delivery of doxorubicin. Int J Nanotechnol Sci Environ 5:13–25.
  • Ali I, Rahis-Uddin, Salim K, Rather MA, Wani WA, Haque A. 2011. Advances in nano drugs for cancer chemotherapy. Curr Cancer Drug Targets. 11:135–146.
  • Alimirzalu S, Akbarzadeh A, Abbasian M, Alimohammadi S, Davaran S, Hanifehpour Y, et al. 2014. Synthesis and study of physicochemical characteristics of Fe3O4 magnetic nanocomposites based on poly(Nisopropylacrylamide) for anti-cancer drugs delivery. Asian Pac J Cancer Prev, 15:49–54.
  • Alizadeh E, Akbarzadeh A, Eslaminejad MB, Barzegar A, Hashemzadeh S, Nejati-Koshki K, Zarghami N. 2014a. Up-regulation of Liver enriched Transcription Factors (HNF4a and HNF6) and Liver Specific MicroRNA (miR-122) by Inhibition of Let-7b in Mesenchymal Stem Cells. Chem Biol Drug Des 85:600–608.
  • Alizadeh E, Zarghami N, Eslaminejad MB, Akbarzadeh A, Barzegar A, Mohammadi SA. 2014b. The effect of dimethyl sulfoxide (DMSO) on hepatic differentiation of mesenchymal stem cells. Artif Cells Nanomed Biotechnol. 30:1–8.
  • Anganeh MT, Sadat Tabatabaei Mirakabad F, Izadi M, Zeighamian V, Badrzadeh F, Salehi R, et al 2014. The comparison between effects of free curcumin and curcumin loaded PLGA-PEG on telomerase and TRF1 expressions in calu-6 lung cancer cell line. Int J Biosci. 4:134–145.
  • Avilion AA, Piatyszek MA, Gupta J, Shay JW, Bacchetti S, Greider CW. 1996. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res. 56:645–650.
  • Blackburn E. 2000. The end of the (DNA) line. Nat Struct Biol. 7: 847–850.
  • Blasco MA. 2001. Telomerase in cancer therapy. J Biomed Biotechnol. 1:3–4.
  • Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, et al. 1998. Extension of life-span by introduction of telomerase into normal human cells. Science. 279:396–352.
  • Chung JH, Kim YK, Kim KH, Kwon TY, Vaezmomeni SZ, Samiei M, et al. 2014. Synthesis, characterization, biocompatibility of hydroxyapatite-natural polymers nanocomposites for dentistry applications. Artif Cells Nanomed Biotechnol. 1–8.
  • Daraee H, Eatemadi A, Abbasi E, Fekri Aval S, Kouhi M, Akbarzadeh A. 2014a. Application of gold nanoparticles in biomedical and drug delivery. Artif Cells Nanomed Biotechnol. 1–13.
  • Daraee H, Etemadi A, Kouhi M, Alimirzalu S, Akbarzadeh A. 2014b. Application of liposomes in medicine and drug delivery. Artif Cells Nanomed Biotechnol. 1–11.
  • Davaran S, Akbarzadeh A, Nejati-Koshki K, Alimohammadi S, Ghamari MF, Soghrati MM, et al 2013. In vitro studies of NIPAAM-MAA-VP copolymer-coated magnetic nanoparticles for controlled anticancer drug release J Encapsulation Adsorpt Sci 3:108–115.
  • Davaran S, Rezaei A, Alimohammadi S, Khandaghi AA, Nejati- Koshki K, Nasrabadi HT, Akbarzadeh A 2014. Synthesis and physicochemical characterization of biodegradable star-shaped poly lactide-co-glycolide– β-cyclodextrin copolymer nanoparticles containing albumin Adv Nanopart 3:14–22.
  • Davoudi Z, Akbarzadeh A, Rahmatiyamchi M, Movassaghpour AA, Alipour M, Nejati-Koshki K, et al. 2014. Molecular target therapy of AKT and NF-kB signaling pathways and multidrug resistance by specific cell penetrating inhibitor peptides in HL-60 cells. Asian Pac J Cancer Prev. 15:4353.
  • Dirsch VM, Stuppner H, Vollmar AM. 2001a. Cytotoxic sesquiterpene lactones mediate their death-inducing effect in leukemia T cells by triggering apoptosis. Planta Med. 67:557–559.
  • Dirsch VM, Stuppner H, Vollmar AM. 2001b. Helenalin triggers a CD95 death receptor-independent apoptosis that is not affected by over expression of Bcl-x(L) or Bcl-2. Cancer Res. 61:5817–5823.
  • Eatemadi A, Daraee H, Karimkhanloo H, Kouhi M, Zarghami N, Akbarzadeh A, et al. 2014a. Carbon nanotubes: properties, synthesis, purification, and medical applications. Nanoscale Res Lett. 9:1–13.
  • Eatemadi A, Daraee H, Zarghami N, Yar HM, Akbarzadeh A, Hanifehpour Y. 2014b. Nanofiber; synthesis and biomedical applications. Artif Cells Nanomed Biotechnol. (Epub ahead of print).
  • Ebrahimi E, Akbarzadeh A, Abbasi E, Khandaghi AA, Abasalizadeh F, Davaran S. 2014. Novel drug delivery system based on doxorubicin-encapsulated magnetic nanoparticles modified with PLGA-PEG1000 copolymer. Artif Cells Nanomed Biotechnol.(Epub ahead of print).
  • Ebrahimnezhad Z, Zarghami N, Keyhani M, Amirsaadat S, Akbarzadeh A, Rahmati M, et al. 2013. Inhibition of hTERT gene expression by silibinin-loaded PLGA-PEG-Fe3O4 in T47D breast cancer cell line. BioImpacts 3:67–74.
  • Fallahzadeh S, Bahrami H, Akbarzadeh A, Tayarani M. 2014. High-isolation dual-frequency operation patch antenna using spiral defected microstrip structure. Antennas and Wireless Propagation Letters. IEEE 9:122–124.
  • Fekri Aval S, Akbarzadeh A, Yamchi MR, Zarghami F, Nejati-Koshki K, Zarghami N. 2014. Gene silencing effect of SiRNA-magnetic modified with biodegradable copolymer nanoparticles on hTERT gene expression in lung cancer cell line. Artif Cells Nanomed Biotechnol. 1–6.
  • Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, et al. 1995. The RNA component of human telomerase. Science. 269:1236–1241.
  • Ghalhar MG, Akbarzadeh A, Rahmati M, Mellatyar H, Dariushnejad H, Zarghami N, Barkhordari A. 2014. Comparison of inhibitory effects of 17-AAG nanoparticles and free 17-AAG on HSP90 gene expression in breast cancer. Asian Pac J Cancer Prev. 15:7113–7118.
  • Ghasemali S, Nejati-Koshki K, Akbarzadeh A, Tafsiri E, Zarghami N, Rahmati-Yamchi M, Alizadeh E, et al. 2013. Study of inhibitory effect of β-cyclodextrin-helenalin complex on HTERT gene expression in T47D breast cancer cell line by real time quantitative PCR (q-PCR) Asian Pac J Cancer Prev 14:6949–6953.
  • Grill AE, Johnston NW, Sadhukha T, Panyam J. 2009. A review of select recent patents on novel nanocarriers. Recent Pat Drug Deliver Formul 3:137–142.
  • Hankey. 1992. Cancer statistics review 1973–1989. National Cancer Institute, NIH Pub. 92–2789:1–8.
  • Hosseininasab S, Pashaei‐Asl R, Khandaghi AA, Nasrabadi HT, Nejati‐Koshki K, Akbarzadeh A, et al. 2014. Synthesis, characterization, and In vitro studies of PLGA‐PEG nanoparticles for oral Insulin delivery. Chem Biol Drug Des. 84:307–315.
  • Huang PR, Yeh YM, Wang TC. 2001. Potent inhibition of human telomerase by helenalin. Cancer Lett. 227:169–174.
  • Jeong JH, Lim DW, Han DK, Park TG. 2000. Synthesis, characterization and protein adsorption behaviors of PLAGA/PEG di-block co-polymer blend films. Colloids Surf B Biointerfaces. 18:371–379.
  • Karnoosh-Yamchi J, Mobasseri M, Akbarzadeh A, Davaran S, Ostad-Rahimi AR, Hamishehkar H, et al. 2014. Preparation of pH sensitive insulin-loaded nano hydrogels and evaluation of insulin releasing in different pH conditions. Mol Biol Rep. 41: 6705–6712.
  • Kennedy S, Geradts J, Bydlon T, Brown JQ, Gallagher J, Junker M, et al. 2010. Optical breast cancer margin assessment: an observational study of the effects of tissue heterogeneity on optical contrast. Breast Cancer Res. 12:1–36.
  • Kilian A, Bowtell DD, Abud HE, Hime GR, Venter DJ, Keese PK, et al. 1997. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet. 6:2011–2019.
  • Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, et al. 1994. Specific association of human telomerase activity with immortal cells and cancer. Science. 266:2011–2015.
  • Kouhi M, Vahedi A, Akbarzadeh A, Hanifehpour Y, Joo SW. 2014. Investigation of quadratic electro-optic effects and electro absorption process in GaN/AlGaN spherical quantum dot. Nanoscale Res Lett. 9:131–136.
  • Kyo S, Inoue M. 2002. Complex regulatory mechanisms of telomerase activity in normal and cancer cells: how can we apply them for cancer therapy? Oncogene. 21:688–697.
  • Lingner J, Hughes TR, Shevchenko A, Mann M, Lundblad V, Cech TR. 1997. Reverse transcriptase motifs in the catalytic subunit of telomerase. Science. 276:561–567.
  • Lyss G, Knorre A, Schmidt TJ, Pahl HL, Merfort I. 1998. The anti- inflammatory sesquiterpene lactone Helenalin inhibits the transcription factor NF-kappa B by directly targeting p65. J Biol Chem 273:33508–33516.
  • Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD. 1997. hEST2, the putative human telomerase catalytic subunit gene, is unregulated in tumor cells and during immortalization. Cell. 90:785–795.
  • Mollazade M, Nejati-Koshki K, Akbarzadeh A, Zarghami N, Nasiri M, Jahanban-Esfahlan R, Alibakhshi A. 2013. PAMAM dendrimers arugment inhibitory effect of curcumin on cancer cell proliferation: possible inhibition of telomerase. Asian Pac J Cancer Prev 14:6925–6928.
  • Nasrabadi HT, Abbasi E, Davaran S, Kouhi M, Akbarzadeh A. 2014. Bimetallic nanoparticles: Preparation, properties, and biomedical applications. Artif Cells Nanomed Biotechnol. 1–5.
  • Nejati-Koshki K, Akbarzadeh A, Pourhasan-Moghadam M, Abhari A, Dariushnejad H. 2013. Inhibition of leptin and leptin receptor gene expression by silibinin-curcumin combination. Asian Pac J Cancer Prev 14:6595–6599.
  • Nejati-Koshki K, Mesgari M, Ebrahimi E, Abbasalizadeh F, Fekri Aval S, Khandaghi AA, et al. 2014. Synthesis and in vitro study of cisplatin-loaded Fe3O4 nanoparticles modified with PLGA-PEG6000 copolymers in treatment of lung cancer. J Microencapsul. 31:815–823.
  • Poole JC, Andrews LG, Tollefsbol TO. 2001. Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT). Gene. 269:1–12.
  • Pourhassan-Moghaddam M, Rahmati-Yamchi M, Akbarzadeh A, Daraee H, Nejati-Koshki K, Hanifehpour Y, Joo SW. 2013. Protein detection through different platforms of immuno-loop-mediated isothermal amplification. Nanoscale Res Lett. 8:485.
  • Pourhassan-Moghaddam M, Zarghami N, Mohsenifar A, Rahmati-Yamchi M, Gholizadeh D, Akbarzadeh A, et al. 2014. Watercress-based gold nanoparticles: biosynthesis, mechanism of formation and study of their biocompatibility in vitro. IET Dig Lib 4:5.
  • Rezaei-Sadabady R, Zarghami N, Barzegar A, Eidi A, Akbarzadeh A, Rezaei-Tavirani M. 2013. Studies of the relationship between structure and antioxidant activity in interesting systems, ncluding tyrosol, hydroxytyrosol derivatives indicated by quantum chemical calculations. Soft 2:13–18.
  • Sadat Tabatabaei Mirakabad F, Akbarzadeh A, Zarghami N, Zeighamian V, Rahimzadeh A, Alimohammadi S 2014. PLGA-based nanoparticles as cancer drug delivery systems Asian Pac J Cancer Prev. 15:517–535.
  • Shay JW, Woodring WE. 2005. Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis. 26:867–874.
  • Shay JW, Wright WE. 2000. Hayflick, his limit, and cellular aging. Nat Rev Mol Cell Boil. 1:72–76.
  • Tabatabaei Mirakabad FS, Akbarzadeh A, Milani M, Zarghami N, Taheri-Anganeh M, Zeighamian V, et al. 2014. A Comparison between the cytotoxic effects of pure curcumin and curcumin-loaded PLGA-PEG nanoparticles on the MCF-7 human breast cancer cell line. Artif Cell Nanomed Biotechnol. 1–8.
  • Torbbaghan S. 1999. Annual report of Tehran University of medical sciences district cancer registry (TUMS-DCR). The cancer institute publication, No. 7, 43.
  • Valizadeh A, Mikaeili H, Samiei M, Farkhani SM, Zarghami N, Kouhi M, et al. 2012. Quantum dots: synthesis, bioapplications, and toxicity. Nanoscale Res Lett 7:276.
  • Yi X, Tesmer VM, Savre-Train I, Shay JW, Wright WE. 1999. Both transcriptional and posttranscriptional mechanisms regulate human telomerase template RNA levels. Mol Cell Boil. 19:3989–3997.
  • Yuan M, Wang Y, Li X, Xiong C, Deng X. 2014. Polymerization of lactides and lactones. Synthesis, characterization, and application of amino–terminated poly (ethylene glycol)–co–poly ([e]–caprolactone) block copolymer. Macromolecules. 33:1613–1617.
  • Zimmermann S, Martens UM. 2007. Telomeres and telomerase as targets for cancer therapy. Cell Mol Life Sci. 64:906–921.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.